Scroll to top
Tag: digital therapeutics
09/21/2023

Technology Fueled America’s Youth Mental Health Crisis, But It Can Help End It

Article Excerpt: Sian Leah Beilock is a cognitive scientist who is the new president of Dartmouth College, the first woman to hold that position since the school was founded in 1769. An expert in, among other things, the effect of stress on academic performance, she is starting her tenure by putting health and wellness at the center of her leadership agenda with a focus on the country’s youth mental health crisis…Substance abuse, which is both helping drive the mental health crisis and is drastically undertreated with nearly 90 percent of sufferers going without treatment, offers an example of the power of technology to provide clinical care in underserved areas or in cases in which stigmatization prevents people from seeking the help they need. Lisa Marsch and her team at the Dartmouth Center for Technology and Behavioral Health (CBTH) created and validated the first Food and Drug Administration-cleared digital therapeutic for the treatment of opioid addiction, which provides cognitive behavioral therapy interventions though the user’s digital device and has since helped roughly double rates of abstinence by lowering the threshold for access to treatment.

Full Article: https://tinyurl.com/4v4jkrwd

Article Source: The Washington Post

08/17/2023

Dartmouth’s Latin American Community Explores Innovation

Article Excerpt: Over the past decade, Dartmouth has formed multiple partnerships in Latin America. The center that (Lisa) Marsch directs— the only National Institute on Drug Abuse-designated center of excellence in digital therapeutics—is collaborating with researchers, insurers, and patient advocacy groups in Latin America as well as government organizations, such as the Ministry of Health in Colombia and National Institute of Mental Health in Peru, to create a new mental health service delivery model for Latin America that will provide better evidence-based care.

Full Article: https://tinyurl.com/r9wpyxzz

Article Source: Dartmouth News

07/25/2023

Digital Therapeutics Provide Benefits but Require Further Research

Article Excerpt: A Substance Abuse and Mental Health Services Administration (SAMHSA) Advisory report indicated that while digital therapeutics (DTx) can address care barriers, such as limited care access and high costs, development efforts are on the rise, prompting further considerations… Research indicates that DTx are projected to grow in the coming years. A part of the National Institutes of Health (NIH), the National Institute on Drug Abuse (NIDA) funds a Center for Technology and Behavioral Health (CTBH) that guides the creation and application of digital health resources for various conditions, often providing grants.

Full Article: https://tinyurl.com/2uk59muy

Article Source: mHealth Intelligence

07/21/2023

FDA Clears Prescription Digital Behavioral Therapeutic for Type 2 Diabetes

Article Excerpt: The Food and Drug Administration (FDA) has cleared AspyreRx™, a prescription digital behavioral therapeutic device for adults with type 2 diabetes.The device is intended to provide cognitive behavioral therapy (CBT), as an adjunct to standard of care, to patients aged 18 years and older with type 2 diabetes under the care of a health care provider. Prescribed in 90-day increments, the digital therapeutic delivers CBT through a mobile application in a weekly, step-by-step process to help patients improve glycemic control.

Full Article: https://tinyurl.com/hx63366n

Article Source: Psychiatry Advisor

07/17/2023

This AI Chatbot Has Helped Doctors Treat 3 Million People–And May Be Coming To A Hospital Near You

Article Excerpt: The problem with turning to the internet for medical advice is that you can come away thinking that you either have a headache or a brain tumor – but the reality is you probably just have a headache. With K Health, Allon Bloch is creating an antidote to “Dr. Google” that ingests your symptoms and medical history via an AI-powered chatbot, sifts through the data of millions of patients and suggests a medical condition based on how you compare to other people like you. “We’re trying to mimic the best doctor in the world,” says Bloch, 53, cofounder and CEO of the seven-year-old New York-based startup.

Full Article: https://tinyurl.com/4awtf4ua

Article Source: Forbes

07/12/2023

Making Digital Interventions Accessible and Affordable

Article Excerpt: As the nation grapples with soaring demand for mental health services amid a provider shortage, more psychologists are considering the benefits of digital therapeutics—evidence-based interventions available to patients on their mobile devices. These tools have the potential to help people struggling with substance use disorders, anxiety, insomnia, and other conditions. But there is a major hurdle blocking widespread access: Using digital therapeutics in practice is not usually covered by health insurance. The costs for the software alone can range from approximately $300 to $1,500 annually—fees that are out of reach for many patients.

Full Article: https://tinyurl.com/23dws648

Article Source: American Psychological Association

06/21/2023

ISPOR 2023 Trinity Panel: Enabling Patient Access to Digital Therapeutics – The Optimal Approach?

Article Excerpt: Monica Martin de Bustamante, Sr. Partner of Trinity’s Evidence, Value, Access, and Pricing (EVAP) team, moderated an exciting conversation at ISPOR 2023 Global in Boston earlier this month. Monica spoke with Lisa Marsch, Ph.D., Benjamin Parcher, PharmD, MS, and Fulton Velez, MD, MS, MBA, all experts in the field of Digital Therapeutics (DTx), about the role of evidence development in the approval of DTx to date, and what evidence development requirements could look like in the next five years.

Full Article: https://tinyurl.com/bp8ap3re

Article Source: Trinity Life Sciences

05/12/2023

Health Inequities Impact on Digital Therapeutics

Article Excerpt: When we look at health inequities, we’ve been using different applications to bridge some of those inequities, primarily around language. We still have a long way to go with some of the cultural barriers, but we can slowly break down some of them and instill a greater understanding with different populations by putting information in front of them in a way that engages them.

Full Article: https://tinyurl.com/25f7cmc2

Article Source: Managed Healthcare Executive

03/22/2023

Digital Health Tech: A Solution to Substance Use Disorders?

Article Excerpt: Healthcare is turning towards tech to develop effective therapies for substance use disorders
While there are several well-established pharmaceutical treatment options available for smoking cessation, and for opioid and alcohol use disorders, there is still a high demand for more effective therapies. According to GlobalData’s Medical Device Pipeline Analytics, there are 61 products in development for treating substance abuse disorders classed as healthcare IT.

Full Article: https://tinyurl.com/3unbwpmh

Article Source: Medical Device Network